good opportunity to addbig breakout on monthly
sustained well above key resistance level
holding very strong in weak market
sales increasing
eps increasing
reduced debt to zero
high cash
promoter buying
already holding my position from past few months
will add more it monthly candle closes strong ( monthly closing after
1.18INR
15.21 MINR
653.49 MINR
4.71 M
About SANDU PHARMACEUTICALS LTD.
Sector
CEO
Umesh Bhaskar Sandu
Headquarters
Mumbai
Website
Employees (FY)
323
Founded
1899
ISIN
INE751D01014
FIGI
BBG000DX3VG3
Sandu Pharmaceuticals Ltd. engages in the manufacture and marketing of Ayurvedic medicines. It offers its products under the Berbenteron suspension, Berbenteron tablets, Bilagyl, Debix, Elegance Oil, Ephenin, Haemol Forte, Madiphal Rasayan, Osteon D, Pregutero, Sarak, Shatari, Stresan, Jaundex, Vanari Kalpa, Vimfix, Whoopin and Pentazyme brands. The company was founded on May 10, 1899 and is headquartered in Mumbai, India.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of SANDUPHQ is 63.10 INR — it has increased by 0.96% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange SANDU PHARMACEUTICALS LTD. stocks are traded under the ticker SANDUPHQ.
Yes, you can track SANDU PHARMACEUTICALS LTD. financials in yearly and quarterly reports right on TradingView.
Like other stocks, SANDUPHQ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SANDU PHARMACEUTICALS LTD. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 323.00 employees. See our rating of the largest employees — is SANDU PHARMACEUTICALS LTD. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SANDU PHARMACEUTICALS LTD. EBITDA is 21.72 M INR, and current EBITDA margin is 3.80%. See more stats in SANDU PHARMACEUTICALS LTD. financial statements.